APC News
Tate & Lyle and APC Microbiome Ireland announce publication of joint intellectual property on new synbiotic fibre product
Tate & Lyle and APC Microbiome Ireland announce publication of joint intellectual property on new synbiotic fibre product
London, 26 August 2022: Tate & Lyle PLC, a world leader in ingredient solutions for healthier food and beverages, in partnership with APC Microbiome Ireland, a Science Foundation Ireland (SFI) Research Centre, is pleased to announce the publication of its jointly filed international patent application for a synbiotic fibre technology that has shown positive preliminary results in metabolic health.
The technology uses a new combination of a probiotic, Lactobacillus mucosae, and soluble dietary fibres which could lead to a number of positive metabolic health changes including in heart health, weight management, liver health, potentially improving immunity, lowering inflammation markers, and improving gut health.
The preliminary clinical research work on this jointly developed synbiotic ingredient, a combination of Tate & Lyle’s proprietary PROMITOR® fibre, and a proprietary shared by University College of Cork (UCC) and Teagasc Lactobacillus strain, has shown substantial and promising cardiometabolic health benefits. APC Principal Investigators Paul Ross, Catherine Stanton, Noel Caplice are co-inventors on the patent as well as project leads.
Tate & Lyle and APC Microbiome Ireland have an ongoing research partnership, which has recently been expanded and extended, looking into the metabolic pathways that could affect the relationship between the microbiome and health. It was this research partnership that led to this jointly filed patent application for this new ingredient technology.
Dr Kavita Karnik, Global Head, Nutrition & Regulatory Affairs at Tate & Lyle, said: “We are delighted, following our initial two-year research project with APC Microbiome, to have our joint patent application published for this ingredient technology that uses our PROMITOR® fibre. The health benefits this new synbiotic fibre ingredient could bring, such as improving heart health and tackling obesity, are exciting and another step on our journey to live our purpose of Transforming Lives through the Science of Food.
“As a science-driven organisation, we are pleased to be continuing our research with APC Microbiome Ireland, looking into the gut microbiome and the positive role fibres can play in improving our health.”
Prof Paul Ross, Director APC Microbiome Ireland, said: “This is an exciting announcement, and we are looking forward to continuing to work with Tate & Lyle to further uncover the health benefits of synbiotics.”
For more on this story contact:
Shelley DeBere
Global External Corporate Comms Manager
Shelley.DeBere@tateandlyle.com
07584 540358
Tina Darb
APC Microbiome Ireland Communications Manager
tdarb@ucc.ie
00 353 87 7826500
About APC Microbiome Ireland:
APC Microbiome Ireland is a world-leading SFI Research Centre based in University College Cork and Teagasc. It was formed in 2003 with funding from Science Foundation Ireland and in conjunction with key industry partners. APC represents a seamless collaboration between University College Cork and Teagasc (the Irish Agriculture and Food Development Authority).
It is widely recognised that the gut microbiota plays an important role in human health and has become one of the most dynamic, complex and exciting areas of research in both food and pharmaceutical arenas. Over the last decade APC has established itself as one of the leading global centres in gut microbiota research.
APC has made several landmark discoveries and has published over 3,000 research articles in peer-reviewed journals, generating many journal covers and associated editorials. Recent research areas being led by APC include the development of new diagnostics or biomarkers of health or risk of disease (e.g., colon cancer) based on analysis of the microbiota; exploring the mechanisms by which the microbiota may be favourably mobilised or manipulated (e.g., by bacteriophage) to promote health and ‘mining’ the microbiota for new drugs (e.g. smart antibiotics) and functional food ingredients. For more information, please visit https://apc.ucc.ie or follow APC Microbiome Ireland on Twitter, LinkedIn, Instagram or Facebook
